Post-transcriptional regulation of plasminogen activator inhibitor type-1 expression in human pleural mesothelial cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 43, Issue 3, 2010, Pages 358-367

  Shetty, Sreerama ^a   Velusamy, Thirunavukkarasu ^a   Shetty, Rashmi S ^a   Marudamuthu, Amarnath S ^a   Shetty, Shwetha K ^a   Florova, Galina ^a   Tucker, Torry ^a   Koenig, Kathy ^a   Shetty, Praveenkumar ^a   Bhandary, Yashodhar P ^a   Idell, Steven ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

Mesothelial cells; PAI 1; Post transcriptional regulation

Indexed keywords

BETA GLOBIN; MESSENGER RNA; PHOSPHOGLUCONATE DEHYDROGENASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; CARCINOGEN; CYCLOHEXIMIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN SYNTHESIS INHIBITOR; SERPINE1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; MESOTHELIUM CELL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REGULATORY MECHANISM; CELL CULTURE; CYTOLOGY; EPITHELIUM; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; MESOTHELIOMA; METABOLISM; NORTHERN BLOTTING; PLEURA; PLEURA TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROCESSING; RNA STABILITY; WESTERN BLOTTING;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CARCINOGENS; CELLS, CULTURED; CYCLOHEXIMIDE; EPITHELIUM; GENE EXPRESSION REGULATION; HUMANS; MESOTHELIOMA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLEURA; PLEURAL NEOPLASMS; PROTEIN SYNTHESIS INHIBITORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA STABILITY; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 77956643809     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2009-0046OC     Document Type: Article

References (41)

1. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 1985;44:139-266.
2. Liotta LA, Stetler-Stevenson WG, Steeg PS. Cancer invasion and metastasis: positive and negative regulatory elements. Cancer Invest 1991;9:543-551.
3. Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993;73:161-195. (Pubitemid 23065437)
4. Sprengers ED, Kluft C. Plasminogen activator inhibitors. Blood 1987;69:381-387.
5. Mazar AP, Henkin J, Goldfarb RH. The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis. Angiogenesis 2000;3:15-32. (Pubitemid 129644777)
6. Idell S, James KK, Levin EG, Schwartz BS, Manchanda N, Maunder RJ, Martin TR, McLarty J, Fair DS. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 1989;84:695-705. (Pubitemid 19197006)
7. Bertozzi P, Astedt B, Zenzius L, Lynch K, LeMaire F, Zapol W, Chapman HA Jr. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med 1990;322:890-897. (see comments). (Pubitemid 20108378)
8. Idell S, Girard W, Koenig KB, McLarty J, Fair DS. Abnormalities of pathways of fibrin turnover in the human pleural space. Am Rev Respir Dis 1991;144:187-194.
9. Idell S, Allen T, Chen S, Koenig KB, Mazar A, Azghani A. Intrapleural activation, processing, efficacy, and duration of protection of single-chain urokinase in evolving tetracycline-induced pleural injury in rabbits. Am J Physiol Lung Cell Mol Physiol 2007;292:L25-L32. (Pubitemid 46103427)
10. Philip-Joet C, Alessi M-C, Philip-Joet C, Aillaud M, Barriere J-R, Arnaud A, Juhan-Vague I. Fibrinolytic and inflammatory processes in pleural effusions. Eur Respir J 1995;8:1352-1356.
11. Idell S, Pueblitz S, Emri S, Gungen Y, Gray L, Kumar A, Holiday D, Koenig KB, Johnson AR. Regulation of fibrin deposition by malignant mesothelioma. Am J Pathol 1995;147:1318-1329.
12. Damjanovich T, Turzó C, Adány R. Factors involved in the plasminogen activation system in human breast tumours. Thromb Haemost 1994;71:684-691.
13. Emeis JJ, Kooistra T. Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J Exp Med 1986;163:1260-1266. (Pubitemid 16000422)
14. Sawdey M, Podor TJ, Luskutoff DJ. Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells: induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha. J Biol Chem 1989;264:10396-10401. (Pubitemid 19161600)
15. Andreasen PA, Pyke C, Riccio A, Kristensen P, Nielsen LS, Lund LR, Blasi F, Dano K. Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells. Mol Cell Biol 1987;7:3021-3025. (Pubitemid 17133923)
16. Kooistra T, Bosma PJ, Tons HAM, Van den Berg AP, Meyer P, Princen HMG. Plasminogen activator inhibitor 1: biosynthesis and mRNA level are increased by insulin in cultured human hepatocytes. Thromb Haemost 1989;62:723-728. (Pubitemid 19267426)
17. Mayer M, Lund LR, Riccio A, Skouv J, Nielsen LS, Stacey SN, Dano K, Andreasen PA. Plasminogen activator inhibitor type-1 protein, mRNA and gene transcription are increased by phorbol esters in human rhabdomyosarcoma cells. J Biol Chem 1988;263:15688-15693.
18. Bergstrom M, Falk P, Holmdahl L. Effect of acidosis on expression of mesothelial cell plasminogen activator inhibitor type-1. Surg Endosc 2006;20:1448-1452. (Pubitemid 44451262)
19. Shetty S, Idell S. Posttranscriptional regulation of plasminogen activator inhibitor-1 in human lung carcinoma cells in vitro. Am J Physiol Lung Cell Mol Physiol 2000;278:L148-L156.
20. Rougier JP, Guia S, Hagege J, Nguyen G, Ronco PM. PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: transcriptional regulation by TGF-beta 1. Kidney Int 1998;54:87-98.
21. Idell S, Zwieb C, Kumar A, Koenig KB, Johnson AR. Pathways of fibrin turnover of human pleural mesothelial cells in vitro. Am J Respir Cell Mol Biol 1992;7:414-426.
22. Holmdahl L, Ivarsson ML. The role of cytokines, coagulation, and fibrinolysis in peritoneal tissue repair. Eur J Surg 2002;165:1012-1019.
23. Shetty S, Idell S. A urokinase receptor mRNA binding protein from rabbit lung fibroblasts and mesothelial cells. Am J Physiol 1998;274:L871-L882.
24. Idell S. Endothelium and disordered fibrin turnover in the injured lung: newly recognized pathways. Crit Care Med 2002;30:S274-S280.
25. Tucker TA, Dean C, Komissarov A, Koenig K, Mazar A, Pendurthi U, Allen TC, Idell S. The urokinase receptor supports tumorigenesis of human malignant pleural mesothelioma cells. Am J Respir Cell Mol Biol (In press)
26. Shetty S, Idell S. Urokinase induces expression of its own receptor in Beas2B lung epithelial cells. J Biol Chem 2001;276:24549-24556.
27. Shetty S, Muniyappa H, Halady PKS, Idell S. Regulation of urokinase receptor expression by phosphglycerate kinase. Am J Respir Cell Mol Biol 2004;31:100-106.
28. Olman MA, Hagood JS, Simmons WL, Fuller GM, Vinson C, White KE. Fibrin fragment induction of plasminogen activator inhibitor transcription is mediated by activator protein-1 through a highly conserved element. Blood 1999;94:2029-2038.
29. Kutz SM, Hordines J, McKeown-Longo PJ, Higgins PJ. TGF-beta1-induced PAI-1 gene expression requires MEK activity and cell-to-substrate adhesion. J Cell Sci 2001;114:3905-3914.
30. Suzuki E, Kim S, Cheung HK, Corbley MJ, Zhang X, Sun L, Shan F, Singh J, Lee W-C, Albelda SM, et al. A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection. Cancer Res 2007;67:2351-2359.
31. Kumar-Singh S, Weyler J, Martin MJ, Vermeulen PB, Van Marck E. Angiogenic cytokines in mesothelioma: a study of VEGF, FGF-1 and -2, and TGF beta expression. J Pathol 1999;189:72-78.
32. Bhandary YP, Velusamy T, Shetty PK, Shetty RS, Idell S, Cines DB, Jain D, Bdeir K, Abraham E, Tsuruta Y, et al. Posttranscriptional regulation of uPAR expression in lipopolysaccharide-induced acute lung injury. Am J Respir Crit Care Med (In press)
33. Fattal PG, Schneider DJ, Sobel BE, Billadello JJ. Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulin-like growth factor 1. J Biol Chem 1992;267:12412-12415.
34. Bosma PJ, Kooistra T. Different induction of two plasminogen activator inhibitor 1 mRNA species by phorbol ester in human hepatoma cells. J Biol Chem 1991;266:17845-17849.
35. Heaton JH, Tilmann-Bogush M, Leff NS, Gelehrter TD. Cyclic nucleotide regulation of type-1 plasminogen activator-inhibitor mRNA stability in rat hepatoma cells: identification of cis-acting sequences. J Biol Chem 1998;273:14261-14268.
36. Tilmann-Bogush M, Heaton JH, Gelehrter TD. Cyclic nucleotide regulation of PAI-1 mRNA stability: identification of cytosolic proteins that interact with an a-rich sequence. J Biol Chem 1999;274:1172-1179.
37. Kietzmann T, Samoylenko A, Roth U, Jungermann K. Hypoxia-inducible factor-1 and hypoxia response elements mediate the induction of plasminogen activator inhibitor-1 gene expression by insulin in primary rat hepatocytes. Blood 2003;101:907-914.
38. Heaton JH, Dlakic WM, Dlakic M, Gelehrter TD. Identification and cDNA cloning of a novel RNA-binding protein that interacts with the cyclic nucleotide-responsive sequence in the type-1 plasminogen activator inhibitor mRNA. J Biol Chem 2001;276:3341-3347.
39. Hirashima Y, Kobayashi H, Suzuki M, Tanaka Y, Kanayama N, Terao T. Transforming growth factor-{beta}1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an upregulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells. J Biol Chem 2003;278:26793-26802.
40. Kozar RA, Weibel CJ, Cipolla J, Klein AJP, Haber MM, Abedin MZ, Trooskin S. Antioxidant enzymes are induced during recovery from acute lung injury. Crit Care Med 2000;28:2486-2491.
41. Srivastava SK, Beutler E. Gluthatione metabolism of erythrocyte: the enzymic cleavage of glutathione-haemoglobin preperations by glutathione reductase. Biochem J 1989;119:353-358.